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Enhancement of the Hepatotoxicity of
Chloroform in B6C3F1 Mice by Corn Oil:
Implications for Chloroform Carcinogenesis
by Richard J. Bull,* Janice M. Brown,t Earle A.
Meierhenry,t Ted A. Jorgenson,t Merrel Robinson,* and
Judith A. Stobert
A recent study of the ability of chloroform in drinking water to produce cancer reported that male
Osborne-Mendel rats developed renal tumors, butthatfemaleB6C3F1 micefailedtodevelophepatocellular
carcinomas. The results obtained in the male Osborne-Mendel rats were comparable to those observed in
an earlier study sponsored by the National Cancer Institute (NCI). On the other hand, the lack of an
increased incidence of hepatocellular carcinomas in female B6C3F1 mice was in sharp contrast to pre-
viously reported results. The doses of chloroform used were comparable to that which produced an 85%
incidence in the NCI study.
We have investigated the extent to which the vehicle might be responsible for the different results in
these two studies by examining the differential effects ofchloroform when it was administered by gavage
using corn oil versus a 2% Emulphor suspension as the vehicle. Male and female B6C3F1 mice were
administered chloroform at 60, 130, and270 mg/kgperdayfor 90days. At sacrifice, bodyand organ weights
were measured, and blood was recovered to perform the following serum chemistry measurements (in
order ofpriority): glutamate oxalacetate transaminase (SGOT), lactate dehydrogenase (LDH), blood urea
nitrogen (BUN), and triglyceride (TG) levels. The liver was sectioned for histopathological examination.
Chloroform increased SGOT levels significantly only when administered in corn oil at a dose of 270 mg/
kg in both male and female mice. It had no effect on LDH activity. There was a small increase in BUN
when chloroform was administered in corn oil, but not when administered in 2% Emulphor. When ad-
ministered in corn oil, chloroform significantly decreased serum TG levels but was without effect on this
parameter when administered in 2% Emulphor. Chloroform decreased body weight and increased liver
weight with both vehicles, but the effects were significantly greater when it was administered in corn oil.
Mice administered chloroform in corn oil displayed a significant degree of diffuse parenchymal degen-
eration (5 of 10 males and 1 of 10 females) and mild to moderate early cirrhosis (5 of 10 males and 9 of
10females); significant pathological lesions were notobserved intheanimalsadministeredcornoil without
chloroform nor in mice receiving chloroform in 2% Emulphor.
These data indicate that administration of chloroform by corn oil gavage results in more marked hep-
atotoxic effects than observed when it is provided in an aqueous suspension. A major difference between
two recent carcinogenesis bioassays of chloroform in this same mouse strain was the vehicle used; corn
oil in the study that yielded an increased incidence of hepatocellular carcinoma (2) and drinking water
in the negative bioassay reported by Jorgenson et al.
Introduction
Chloroform is one of a group of chemicals that is
formed during the chlorination of drinking water (1,2)
and from the treatment of experimental animals with
aqueous solutions ofchlorine byoral gavage (3,4). These
observations gave rise to considerable public concern
when it was shown that chloroform was capable of in-
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creasingthe incidence ofrenal tumors inmale Osborne-
Mendel rats and liver tumors in B6C3F1 mice (5).
From the time they were first observed, chloroform-
induced liver tumors were associated with overt necro-
sis ofthe organ (6). This observation has led a number
ofpeopletosuggestthattumorsarisingfromchloroform
treatments are secondary to tissue necrosis and re-
peated reparative hyperplasia (7). Adding to this ar-
gument has been the fact that chloroform and/or its
metabolites do not interact extensively with DNA in
vivo (7-10). These observations have been generally
supported by the absence ofgenotoxic activity ofchlo-
roform in bacterial systems (11-14). Chloroform alsoBULL ET AL.
Table 1. Tubular-cell adenoma and adenocarcinoma in male
Osborne-Mendel rats treated with chloroform.
NCI study Jorgenson et al. study
Probability
Animals of death
Dose, with Dose, with
mg/kga (N)b tumors, %C mg/kgd (N)b tumore
0 19 0 0 301 0.06
Matched 0 50 0.04
19 313 0.03
38 148 0.08
90 50 8 81 48 0.08
180 50 26 160 50 0.20
aDose administered in corn oil, by gavage, 5 days/week for 78
weeks.
bEffective number of animals per group.
cIncidence not adjusted for age.
dTime-weighted-average doses administered in drinking water 7
days/week for 104 weeks.
eTumor incidence adjusted for intercurrent mortality.
failed to induce chromosome damage or sister-chro-
matid exchange in human lymphocytes treated in vitro
(13) or mutations at the 8-azoguanine locus in Chinese
hamster lung fibroblast cells (15). On the other hand,
chloroform has been shown to induce mutation in yeast
(16) and to enhance viral transformation ofSyrian ham-
ster ovary cells in vitro (17) and reported by another
group to induce sister-chromatid exchange in human
lymphocytes in vitro and mouse bone marrow cells in
vivo (18). Invivo treatments with chloroformhave been
reported to increase mutagenicity in the urine of mice
and to induce polychromatic erythrocytes (19). Chlo-
roform treatment was reported to increase spermhead
abnormalities inmice inone study (20) andtobewithout
such effects in another (21). In general, to the extent
thatgenotoxic activities havebeenassociated with chlo-
roform, that activity has been weak. Nevertheless, it
is difficult to rule out a role for such activity in the
carcinogenic responses to chloroform without positive
evidence for alternative mechanisms.
The present work was part of a large-scale followup
ofthe original National Cancer Institute (NCI) bioassay
ofchloroform (5). Tumor pathology from this study has
Table 2. Hepatocellular adenoma and carcinomas in female
B6C3F1 mice treated with chloroform.
NCI study Jorgenson et al. study
Animals Animals
Dose, with Dose, with
mg/kge (N) tumors, % mg/kgb (N) tumors, %
0 20 1 0 415 5
Matched 0 47 0
34 410 4
65 142 6
238 45 80 130 47 0
477 41 95 263 44 2
aDose administered in corn oil, by gavage, 5 days/week for 78
weeks.
Time-weighted-average dose administered in drinking water 7
days/week for 108 weeks.
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FIGURE 1. Serum triglyceride levels in male Osborne-Mendel rats
at different periods of exposure to chloroform in their drinking
water at the indicated concentrations. Each experimental group
contained 10 or 20 animals at each time of sacrifice.
been previously reported (22) and is only reviewed in
the present paper. In this paper we report selected
clinical chemistry data obtained in interim sacrifices of
rats subjected totreatments thatparalleled thoseinthe
carcinogenesis study and the results of shorter-term
(90-day) studiesinmicethatweredesignedtodetermine
the extent to which vehicles used in carcinogenesis
bioassays of chloroform influence the hepatoxic re-
sponses to this agent.
Experimental Methods
Treatment ofAnimals
The treatment of male Osborne-Mendel rats in the
carcinogenicity bioassay was previously described by
Jorgenson et al. (22). Inshort, 960rats weredistributed
among six treatment groups that received 0, 200, 400,
900, or 1800 mg of chloroform per liter of drinking
water. The sixth group received no chloroform but was
matched to the high-dose group for drinking water con-
sumption. The groups contained 330, 330, 150, 50, 50,
and 50 animals, respectively, at the start ofthe exper-
iment. Toxicity information presented inthis paperwas
gathered from separate groups ofanimals that received
parallel treatments. In this case, 10 to 20 animals were
treated per dose, per sacrifice time.
Female B6C3F1 mice used in the carcinogenicity
study were assigned in much the same manner (22). In
this case, the groups receivingthe above identified con-
centrations of chloroform in their drinking water had
430, 430, 150, 50, 50, and 50 animals assigned to the
respective groups.
The study ofthe influence ofvehicle on the hepatox-
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Table 3. Effects ofvehicle on general parameters ofthe subchronic toxicity of chloroform in B6C3F1 mice.a
Chloroform dose, Male Female
Parameter mg/kg per day 2% Emulphor Corn oil 2% Emulphor Corn oil
Final body weight, g ± SEM 0 33.6 ± 0.5 35.5 ± 0.4c,d 26.5 ± 0.6 25.4 ± 0.4
60 31.0 ± 0.8 31.7 ± 0.4 25.4 ± 0.6 25.5± 0.7
130 31.6 ± 0.8 30.6 ± 0.5 26.4 ± 0.6 26.0 ± 0.3
270 29.3 ± 0.6d 26.6 ± 0 3c,d 25.4 ± 0.3 24.0 ± 0.7
Liver weight, g ± SEM 0 1.29 ± 0.03 1.17 ± 0.03c 0.98 ± 0.03 1.00 ± 0.04
60 1.18 ± 0.03 1.32 ± 0.03cd 1.09 ± 0.04d 1.19 ± 0.05d
130 1.33 ± 0.05 1.36 ± 0.03d 1.13 ± 0.04d 1.22 ± 0.03d
270 1.36 ± 0.03 1.50 ± 0.02cd 1.22 ± 0.03d 1.39 ± 0.03c,d
Liver/body weight ratio, g/100 g ± SEM 0 4.02 ± 0.49 3.58 ± 0.10C 4.32 ± 0.10 4.38 ± 0.15
60 4.28 ± 0.06 4.67 ± 0.06c,d 4.84 ± 0.lod 5.25 ± 0.10-
130 4.84 ± 0.11d 5.09 ± 0.09d 4.94 ± 0.12" 5.47 ± 0.08cd
270 5.34 ± 0.07d 6.64 ± 09c d 5.58 ± 0.12" 6.86 ± 0.16-
Liver/brain weight ratio, g/g ± SEM 0 2.31 ± 0.30 2.33 ± 0.05C 1.90 ± 0.05 1.96 ± 0.07
60 2.47 ± 0.04 2.72 ± 0.07c 2.14 ± 0.08d 2.31 ± 0.11d
130 2.72 ± 0.10 2.74 ± 0.05" 2.15 ± 0.08d 2.39 ± 0.05
270 2.87 ± 0.06 3.10 ± 0.07bd 2.42 ± 0.05" 2.83 ± 0.03-
aFor each sex and dose level, significant differences between Emulphor and corn oil groups ofp G 0.05 or p s 0.01, respectively, based on
Student's t-test. Number of animals per group = 9 or 10.
bp s 0.05.
cp 0.01.
Significantly different from corresponding control ofp G 0.05 by one-way analysis of variance and pairwise Student's t-test.
eLiver/body weight ratios were determined using the fasted body weights rather than the final body weights.
icity of chloroform in B6C3F1 mice used 80 male and
80 female animals purchased from Simonsen Labora-
tories (Gilroy, CA). Males were 8weeks old and females
6 weeks old at the start of the experiment. Mice were
housed five per cage in hanging polyearbonate cages
containing a hardwood chip bedding (AbSorbDri, May-
wood, NY). Animals were kept on a 12-hr-on, 12-hr-off
light cycle at a room temperature of70 ± 2°F. Animals
were randomly assigned to eight treatment groups con-
taining 10 males and 10 females each; four groups re-
ceived chloroform at doses of0, 60, 130, and 270 mg/kg
usingpurified cornoil(WilseyFoods, Inc., LosAngeles,
CA) as the vehicle, and four groups received the same
doses of chloroform with 2% Emulphor (polyoxyethy-
lated vegetable oil, GAF Corp.) in water as the vehicle.
The volume of administration was 1.0 mL/100 g body
weight with both vehicles, and the material was ad-
ministered by stomach tube once daily for 91-92 con-
secutive days formales and 93-94daysforfemales (i.e.,
the day of sacrifice). Animals were fasted overnight
Table 4. Comparison of clinical chemistry parameters of mice treated with chloroform in corn oil vs. Emulphor for 90 days.
Chloroform dose, Malea Femalea
Parameter mg/kg/day 2% Emulphor Corn oil 2% Emulphor Corn oil
SGOT, mU/mL Control 284 ± 53 181 ± 36 151 ± 27 193 ± 22
(7) (10) (9) (8)
60 142 ± 32 158 ± 31 113 ± 26 126 ± 16
(4) (9) (7) (8)
130 176 ± 43 116 ± 14 169 ± 25 127 ± 14c
(7) (8) (8) (9)
270 167 ± 31 298 + 31 117 ± 17 335 ± 60b,d
(6) (8) (7) (7)
Triglycerides, mg-% Control 58 ± 8 80 ± 10 63 ± 10 64 ± 5
(9) (10) (10) (10)
60 75 ± 12 75 ± 4 62 ± 9 65 ± 5
(10) (9) (10) (10)
130 54 6 60+ 5 50 4 55 ± 5
(9) (10) (10) (9)
270 60 4 43+ 3d 55 3 41 ± 3
(10) (10) (10) (10)
aMean ± SEM, number ofanimals in parentheses.
bSignificantly different from corresponding control at p S 0.05.
'For each sex and dose level, significant differences ofp s 0.05 between Emulphor and corn oil groups were based on Student's t-test.
dSignificant differences ofp s 0.01, as in footnote c.
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Table 5. Effect ofvehicle on chloroform-induced accumulation
of lipid in the liver of B6C3F1 mice.
Chloroform Male Female
dose, 2% 2%
mg/kg/day Emulphor Corn oil Emulphor Corn oil
0 6.6 ± 1.la 7.9 ± 0.7 6.8 ± 0.4 7.5 ± 0.8
60 6.8 ± 0.6 9.4 ± 0.8 7.5 ± 0.3 13.1 ± 1.lb
130 7.6 ± 0.7 7.8 ± 0.4 6.9 ± 0.3 9.2 ± 0.8
270 5.3 ± 0.6 8.0 ± 0.3 6.0 ± 0.4 8.4 ± 0.4
aAverage lipid content in % net weight ± SD. Nine or ten animals
per group.
bSignificantly different from corresponding control at p < 0.01.
before sacrifice. Necropsies were performed on all an-
imals.
Urinalysis, Clinical Chemistry, and
Hematology
Results from the male Osborne-Mendel rats have
been previously reported (23), and only the serum tri-
glyceride results will be reviewed in the present paper.
Urine from mice was collected in individual metabolism
cages 1 daybeforethemiceweresacrificedandanalyzed
byreagentteststripsforpH, protein, glucose, bilirubin,
occult blood, and urobilinogen. Blood from mice was
collected by cardiac puncture on the day of sacrifice.
Serum clinical chemistry and hematology determina-
tions wereperformed as the blood volume collected per-
mitted according to the following order of preference:
triglycerides, lactic dehydrogenase (LDH), serum glu-
tamic-oxalacetic transaminase (SGOT), hematology,
blood urea nitrogen (BUN), creatinine, total protein,
albumin (A), sodium (Na+) and potassium (K+). Hem-
atology samples were processed for hematocrit, hemo-
globin, mean corpuscular volume (MCV), mean corpus-
cular hemoglobin (MCH), mean corpuscular hemoglobin
volume (MCHC), white blood cell counts (WBC), red
bloodcellcounts (RBC), WBCdifferentials, andplatelet
counts.
Histopathology
The brain, liver, spleen, lungs, thymus, kidneys,
heart, and gonads of each mouse were weighed at ne-
cropsy. Four histological slides were prepared from
freshly C02-frozen liver sections of each animal (two
each fromnonadjacent sections ofthe centrallobe). One
slide from each section was stained with Oil Red 0 and
the other with hematoxylin and eosin (H&E). The left
lobe of the liver was processed for quantitative deter-
minationoflipid contentbyorganicsolventpartitioning,
solvent evaporation, and residue weight determina-
tions.
Statistical Analyses
Theeffectsofchloroformonthecorrespondingvehicle
control were compared by using a one-way analysis of
FIGURE 2. Photomicrograph ofliver section from a control B6C3F1 mouse given corn oil in gavage for 90 days. Note regularity ofappearance
ofhepatocytes. V = vein. H&E. Original magnification x 63.
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FIGURE 3. Photomicrograph of liver section from a B6C3F1 mouse given 60 mg/kg chloroform in corn oil for 90 days. Note extensive focal
hepatocyte vacuolation (arrows indicate typical vacuoles). V = vein. Compare with Fig. 1. H&E. Original magnification x63.
variance (ANOVA). Treatment groups were compared
with control groups using pairwise Student's t-tests if
the ANOVA proved to be significant at p < 0.05. The
effects of the same dose of chloroform administered in
different vehicles werecomparedusingStudent's t-test.
Results
Table 1 compares the yield of renal tubular-cell ad-
enomas andadenocarcinomasobtainedintheNCIbioas-
say of chloroform (5) with the more recent results re-
ported by Jorgenson et al. (22). Because the dosage
indicated was administered 7 days/week for 2 years in
the drinking water in the latter study and by gavage
for only 5 days/week for 78 weeks in the NCI study,
the total dose of chloroform administered in the NCI
study is actually somewhat lower relative to the Jor-
genson study than would be surmised from the table.
Nevertheless, the results of the two studies were in
substantial agreement despite the differences in the
mode of chloroform administration.
A substantially different picture emerges when the
yield ofhepatocellular carcinomas inthefemale B6C3F1
mice is compared between these two studies presented
in Table 2. Projecting from the response observed in
the NCI study, a greater than 80% incidence of hepa-
tocellular carcinoma should have been observed in the
Jorgenson et al. (22) study at the highest dose admin-
istered (263 mg/kg per day). Instead, a 2% incidence
was observed relative to the 5% incidence seen in the
control group, and a0% incidence in the smaller control
group that was matched to the high-dose group for
water consumption was observed.
As noted previously (23), few indications of toxicity
were observed in rats exposed to chloroform in their
drinking water. The major clinical chemistry finding
was that serum triglyceride levels were depressed by
chloroform treatment (Fig. 1). This finding was par-
tially, butnotcompletely, explainedbydecreasedwater
consumption (that is assumed to be attributed to an
associated decrease in food consumption). It is difficult
to judge precisely the degree to which intermediate
doses of chloroform add to the serum triglyceride
depression produced by decreased water consumption.
In the high-dose group, this depression was32% to 80%
relative to the group matched to it for water consump-
tionthroughoutthefirst 18months ofthe study. Infact,
chloroforn at the high dose appears to prevent almost
completely an age-related increase in serum triglycer-
ides in the rat. A definite trend in the data indicates
that this effect is seen to a somewhat lesser extent at
concentrations ofchloroform as low as 400 mg/L. Com-
parisons at the 24-month time point were not depend-
ablebecause oftherelativelypoorsurvivalencountered
in certain groups.
Renal pathology was evident in rats from all test
groups. However, there was no clear indication that
renal pathology was either more frequent or more se-
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FIGURE 4. Photomicrograph offrozen liver section from a B6C3F1 mouse given 60 mg/kg chloroform in corn oil for 90 days. Note extensive
vacuolation and dark stain product indicating the presence offat. Compare with Fig. 4. Oil Red 0. Original magnification x63.
vereinanimalsthatreceivedthehighdoseofchloroform
relative to the appropriate control groups.
Someinteractions occurred betweenthevehicleused,
food consumed, and body weight in the experments
designed to determine the impact ofthe vehicle on the
hepatotoxicity of chloroform in B6C3F1 mice (data not
shown). Corn oilgavage substantially reduced food con-
sumption by about 25% in male mice and 15% in female
mice. In both sexes, food consumption was significantly
increased by chloroform in a dose-related manner when
corn oil was administered as the vehicle. This phenom-
enon was not observed in the experiment using 2%
Emulphor as the vehicle.
Table 3 describes the effects of chloroform on liver
weight, liver:body weight, and liver:brain weightratios
when it was administered in corn oil compared to those
associated with the administration ofchloroform in the
2% Emulphor vehicle. Liver weight in male mice was
significantly depressed by corn oil despite the fact that
it significantly increased body weight. As chloroform
doses were increased, however, liverweights were sig-
nificantly increased when corn oil was used as the ve-
hicle, but not when 2% Emulphor was used as the ve-
hicle. Chloroform in corn oil depressed body weight in
male mice to a much greater extent than when admin-
istered in equivalent doses in Emulphor. On the other
hand, it had little effect on body weight when admin-
istered to female mice in either vehicle. Liver weight
was increased with chloroform treatment using both
vehicles in female mice, but to a significantly greater
degree when administered in corn oil. Normalization of
the differential effects ofchloroform on body weight by
expressingthedataasliver:bodyweightandliver: brain
weight ratios provided substantially greater increases
in these ratios when corn oil was used as the vehicle
relative to the use of Emulphor. Consequently, chlo-
roform-induced increases in liver size were quite evi-
dent in both sexes.
Lactic dehydrogenase (LDH) in serum provided no
evidence of organ damage in B6C3F1 mice with either
vehicle. However, serum glutamic oxalacetic transam-
inases (SGOT) increased in a dose-related mannerwhen
chloroformwas administered tomice in acornoilvehicle
(Table 4). This effect was also observed in both sexes.
No such trend was observed when chloroform was ad-
ministered in the same doses in the 2% Emulphor ve-
hicle. In the same manner, serum triglycerides ofmice
became depressed in mice administered chloroform in
corn oil, but not when Emulphor was used as the ve-
hicle.
The lowest dose of chloroform used (60 mg/kg) in-
creased the levels oflipid in the liver ofboth male and
female mice when administered in corn oil (Table 5). At
higher doses, the liver lipid levels decreased in concert
with the depression of serum triglycerides. Lipid ac-
cumulation in liver was not evident when chloroform
was administered in 2% Emulphor.
Figures 2 through 7 are typical photomicrographs ofCHLOROFORM HEPATOTOXICITY AND CARCINOGENICITY
FIGURE 5. Photomicrograph offrozen liver section from a control B6C3F1 mouse given corn oil for 90 days. Oil Red 0. Original magnification
x 63.
liver sections taken from B6C3F1 mice that were
treated with corn oil (controls) or with chloroform dis-
solved in corn oil. H&E-stained liver sections from an-
imals receiving corn oil alone appeared normal with he-
patocytes of uniform size and shape (Fig. 2). Animals
that were administered 60 mg/kg chloroform in corn oil
for 90 days displayed extensive vacuolation with H&E
stain (Fig. 3), and frozen sections provided evidence of
lipid when stained with Oil Red 0 (Fig. 4), whereas
frozen sections from control animals did not (Fig. 5).
The accumulation of lipid in the dose group was quite
marked in three of nine male and three of ten female
animals, adegree ofseverity not observed inthe control
group (corn oil only) nor in animals treated with higher
doses ofchloroform. Animals that had received 270 mg/
kg of chloroform per day in corn oil displayed an ex-
tensive disruption of the normal hepatic architecture
that was accompanied by infiltration of inflammatory
and spindle cells (Fig. 6). The hepatocytes assumed bi-
zarre shapes, were often substantially enlarged in size,
but were only mildly vacuolated in animals subjected to
this dose of chloroform. These enlarged hepatocytes
were also observed in frozen sections (Fig. 7), but stain-
ing with Oil Red 0 was substantially reduced in the
high-dose group relative to that observed in the groups
treated with 60 mg/kg of chloroform in corn oil The
pathologist judged that five often male mice and seven
of ten female mice displayed evidence of mild to mod-
erate early cirrhosis at this high dose.
No such pathology was noted in animals administered
these same doses ofchloroform in 2% Emulphor. Inthis
case, pathology was limited to minimal focal necrosis in
two ofnine male mice and two often female mice at 130
mg/kg and in two of ten female animals at 270 mg/kg.
Onemalemouseoftenat270mg/kgchloroforminEmul-
phor displayed mild focal necrosis in the liver. In ad-
dition, no significant trends in the lipid content of the
liver were apparent in these animals when frozen sec-
tions were observed after stainingwith Oil Red 0 (data
not shown).
Discussion
It is clear from the present results that the hepato-
toxicity of chloroform is strongly dependent on the
means ofadministration in B6C3F1 mice. The substan-
tially different results obtained in the NCI (5) and the
Jorgenson et al. (22) studies ofchloroform-induced liver
tumors in this same strain of mice may have also re-
sulted from the dissimilarity in the means by which
chloroform was administered. No such dependency on
the means of chloroform administration was observed
in the production ofrenal tumors in male Osborne-Men-
del rats.
One effect of chloroform that appears to be common
to both species is a substantial decrease in serum tri-
glycerides concentrations. In the chronic studies where
chloroform was administered in drinking water, a sig-
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FIGURE 6. Photomicrograph of liver section from a B6C3F1 mouse given 270 mg/kg chloroform in corn oil for 90 days. Note disruption of
hepatic architecture with infiltration ofsmall inflammatory and spindle cells (open arrows), enlarged bizarre hepatocyte (solid arrow), and
occasional mildly vacuolated hepatocytes (double solid arrows). V = vein. H&E. Original magnification x63.
nificant dose-related increase in liver fat occurred in
B6C3F1 mice (23). A small, but significant, increase in
liver lipid was observed only at the highest doses in
male Osborne-Mendel rats. Despite these qualitative
similarities, the two species appear to be divergent in
sensitivity to chloroform-induced hepatoxicity as well
as to chloroform-induced hepatomas.
Accumulation oflipid inthe liverofB6C3F1 mice was
not as apparent in the present study when chloroform
was administered in Emulphor. Although lipid accu-
mulation was apparent in mice treated with 60 mg/kg
chloroform in corn oil, the effect was not observed at
higher doses. The biphasic nature ofthis dose-response
relationship appeared to be related to the formation of
atypical, enlarged hepatocytes and to the development
ofscarring typical ofthe initial stages ofcirrhosis ofthe
liver. Decreased levels ofserum triglycerides may also
have contributed to a lesser accumulation oflipid in the
liver at higher doses ofchloroform. However, the rea-
sons forthe differences inlipid accumulationinthe liver
when Emulphor was used as a vehicle compared to that
associated with drinking water exposures are not read-
ily apparent.
In the present study, the hepatotoxic effects ofchlo-
roform administered in two different vehicles in
B6C3F1 micewerecompareddirectly. Agreaterdegree
of hepatotoxicity was observed, using gross measure-
ments ofliverweight, clinicalchemistry, and direct his-
topathological examination when corn oil was used as
the vehicle. All three lines of evidence indicated that
chloroform administered in corn oil is more hepatotoxic
to the liver ofB6C3F1 mice than when administered in
a vehicle containing little or no unsaturated lipids.
Withey et al. (24) demonstrated that the use of a corn
oil vehicle actually slows the rate ofchloroform absorp-
tion from the gastrointestinal tract. Consequently, it is
unlikelythatthedifferenceinresponsecanbeexplained
on simple pharmacokinetic grounds.
The question of whether the carcinogenic responses
to chloroform in the mouse liver were secondary to the
hepatotoxic effects ofthis agent dates to the early ob-
servations of Eschenbrenner and Miller (6). These au-
thors found that administration ofchloroform to strain
A mice induced hepatomas only at doses that produced
frank liver necrosis. The supposition that chloroforn
induces liver tumors secondary to such tissue damage
has been indirectly supported by the lack of a clear
indicationthatitis capable ofinteractingwith DNA (7-
10). On the other hand, Reitz et al. (8) found that chlo-
roformdoesincreasetheincorporation of[3H]thymidine
into liver DNA at doses of60 mg/kg and above (unfor-
tunately these authors did not specify the vehicle in
which chloroform was administered). In a study that
more directly addresses the influence ofvehicle, Moore
et al. (25) found that the incorporation of[3H]thymidine
intoliverandkidneyofCFLPoutbredSwissalbinomice
56CHLOROFORM HEPATOTOXICITY AND CARCINOGENICTY 57
U, P-Qk W-4,q1A S
H-Z .9.
33,
.. . ....... M
41
C
15
W
FIGURE 7. Photomicrograph of frozen liver section from a B6C3F1 mouse given 270 mg/kg chloroform in com oil for 90 days. Note hepatic
vacuolation (open arrows) among large bizarre hepatocytes (closed arrows). Oil Red 0. Original magnification x 63.
was considerably enhanced when chloroform was ad-
ministered in a corn oil vehicle compared to when it was
administered using a toothpaste base as the vehicle.
These data suggest that chloroform induced a regener-
ative hyperplasia that could stimulate the proliferation
of spontaneously initiated neoplastic cells.
Newberne et al. (26) found that incorporation ofcorn
oil into the diet increases the yield of aflatoxin B1-in-
duced tumors inrats. This latterobservation would sug-
gest that corn oil itself might promote the growth of
initiated cells. However, the tumor yield observed in
the control animals that received water as the vehicle
in the Jorgenson et al. (22) study were quite consistent
with the yields observed in untreated, historical con-
trols (27) in this same strain ofmice. Consequently, one
is left with the hypothesis that the difference in carcin-
ogenic response to chloroform observed with different
vehicles maybeattributabletointeractionsbetweenthe
vehicle and chloroform. The present study has not pro-
vided direct evidence for such an effect. However, if
the carcinogenic response in the mouse liver is second-
ary to the hepatotoxic effects of chloroform, such an
interaction might well explain the divergent results ob-
tained in two bioassays of this chemical.
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